Advertisement

China testing blunders stemmed from secret deals with firms

china testing blunders stemmed from secret deals with firms

BEGIN ARTICLE PREVIEW:

WUHAN, China (AP) — In the early days in Wuhan, the first city first struck by the virus, getting a COVID test was so difficult that residents compared it to winning the lottery.Throughout the Chinese city in January, thousands of people waited in hours-long lines for hospitals, sometimes next to corpses lying in hallways. But most couldn’t get the test they needed to be admitted as patients. And for the few who did, the tests were often faulty, resulting in false negatives.The widespread test shortages and problems at a time when the virus could have been slowed were caused largely by secrecy and cronyism at China’s top disease control agency, an Associated Press investigation has found. ADVERTISEMENTThe flawed testing system prevented scientists and officials from seeing how fast the virus was spreading — another way China fumbled its early response to the virus. Earlier AP reporting showed how top Chinese leaders delayed warning the public and withheld information from the World Health Organization, supplying the most comprehensive picture yet of China’s initial missteps. Taken together, these mistakes in January facilitated the virus’ spread through Wuhan and across the world undetected, in a pandemic that has now sickened …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE

The dawn of digital medicine

the dawn of digital medicine

BEGIN ARTICLE PREVIEW:

IN JANUARY Stephen Klasko, chief executive of Jefferson Health, which runs hospitals in Philadelphia, chatted to a bank boss. The financier told him that 20 years ago health care and banking were the only industries yet to embrace the consumer and digital revolution. “Now”, Mr Klasko recalls him adding, “you are alone.”The banker had a point. The McKinsey Global Institute, the in-house think-tank of the eponymous consultancy, reckons that when it comes to digitisation, health care has lagged behind not just banking but travel, retail, carmaking and even packaged goods. Some 70% of American hospitals still fax and post patient records. The CEO of a big hospital in Madrid reports virtually no electronic record-sharing across Spain’s regions when the first wave of covid-19 washed over the country this spring.By exposing such digital deficiencies, the pandemic is at last spurring change. Confronted with shutdowns and chaos, doctors have embraced digital communication and analytics of the sort that has for years been common in other industries. Patients are growing more comfortable with remote and computer-assisted diagnosis and treatment. And enterprising firms, from health-app startups and hospitals to insurers, pharmacies and tech giants such as Amazon, Apple and Google, are scrambling to …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “The dawn of digital medicine”

WIRED Health:Tech 2020: Medical technology and COVID-19

wired health:tech 2020: medical technology and covid-19

BEGIN ARTICLE PREVIEW:

WIRED Health:Tech is one of the most prominent annual conferences exploring technological advances in medicine. This year, the main topics included artificial intelligence, remote surgical systems, and the ongoing fight against COVID-19.All data and statistics are based on publicly available data at the time of publication. Some information may be out of date. Visit our coronavirus hub and follow our live updates page for the most recent information on the COVID-19 pandemic.This year’s WIRED Health:Tech conference took place online last month, in an effort to adapt to the challenges posed by the current pandemic.A range of specialists held presentations about the latest advances in medical technology, including remote surgical systems, e-health, CRISPR technology, and the issue on everyone’s mind this year: how research can combat the COVID-19 pandemic.In this Special Feature, we offer an overview of the panels and main takeaways from the presentations.Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.Throughout many of the WIRED Health:Tech presentations, the recurring theme was how technology is helping — or hindering — the fight against SARS-CoV-2, the coronavirus that has …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “WIRED Health:Tech 2020: Medical technology and COVID-19”

SeaSpine Announces Limited Commercial Launch of its Admiral™ ACP System

seaspine announces limited commercial launch of its admiral™ acp system

BEGIN ARTICLE PREVIEW:

CARLSBAD, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and subsequent first case of its Admiral ACP System. Admiral ACP represents the next generation of anterior cervical plating designed to strike the optimal balance between strength, profile and construct rigidity. Differentiated plate features combined with step-eliminating, innovative instrumentation work seamlessly in the surgeon’s hands to create a more efficient and consistent anterior cervical discectomy and fusion (ACDF) experience.

The first case was completed by Dr. Don Park, Vice Chair of Quality and Safety for the Department of Orthopaedic Surgery at UCLA.  Dr. Park stated: “Admiral’s modular trial drill guides, coupled with its threaded driver, give me ultimate control of my screw trajectory, allowing me to angulate and direct my screws as needed to accommodate my patient’s specific anatomical needs.  This instrumentation is an absolute game changer.”

Admiral ACP is designed to be used as supplemental fixation for ACDF procedures in conjunction with the Company’s interbody offerings, including the 3D-printed Waveform™ C and Shoreline® RT, featuring NanoMetalene® surface technology and Reef Topography.™  Admiral ACP includes 1 …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “SeaSpine Announces Limited Commercial Launch of its Admiral™ ACP System”

Stryker declares a $0.63 per share quarterly dividend

stryker declares a $0.63 per share quarterly dividend

BEGIN ARTICLE PREVIEW:

Kalamazoo, Michigan, Dec. 02, 2020 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable January 29, 2021 to shareholders of record at the close of business on December 31, 2020, representing an increase of 9.6% versus the prior year and previous quarter. 

“We continue to drive solid financial results in a challenging environment, and consistent with our stated capital allocation philosophy, are raising our dividend 9.6%,” said Kevin Lobo, Chairman and Chief Executive Officer. 

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com.

Contacts

For investor inquiries please contact:Preston Wells, Vice President, Investor Relations at 269-385-2600 or preston.wells@stryker.com 

For media inquiries please contact:Yin Becker, Vice President, Communications, Public Affairs and Corporate Marketing at 269-385-2600 or yin.becker@stryker.com

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Stryker declares a $0.63 per share quarterly dividend”

Intertech Plastics Gets with the MedAccred Program

intertech plastics gets with the medaccred program

BEGIN ARTICLE PREVIEW:

Injection molder Intertech Plastics LLC announced today that its medical division has received MedAccred accreditation for its injection molding, over molding, and mechanical assembly services. The designation establishes Intertech’s compliance to critical manufacturing process requirements and places the company among a select group of injection molders serving medical device OEMs. The MedAccred program is administered by the Performance Review Institute and constitutes an industry-managed, consensus-driven approach to ensuring manufacturing process quality throughout the medical device supply chain.

“At Intertech, precision is our purpose. Quality is everyone’s job and we are focused on proactively illuminating the risk of having a defect,” said Jim Kepler, President. “Being among the handful of plastic processors to receive the MedAccred accreditations is a testament to our culture, commitment to innovation, and laser focus on quality.

“The audit process verifies that we have met industry requirements in process capability, equipment, quality controls, qualified personnel, and process validation and eliminates timely steps for our potential customers,” added Kepler. “We want to support medical device manufacturing in the United States, and this is a step in the right direction.”

The medical device division accounts for about half of Intertech Plastics’ overall business, Kepler told PlasticsToday, and …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Intertech Plastics Gets with the MedAccred Program”

Camber Spine’s OLIF Retractor System Receives ‘2020 Best Spine Technology Award’

camber spine’s olif retractor system receives ‘2020 best spine technology award’

BEGIN ARTICLE PREVIEW:

Technology is an Integral Part of the OLIF Technique – a Less Invasive Approach to Spinal Fusion Surgery

KING OF PRUSSIA, PA — December 2, 2020 – Camber Spine, a leading innovator in spine and medical technologies has been presented with Orthopedics This Week’s “2020 Best Spine Technology Award” for its Lateral ALIF / OLIF Retractor System, an integral part of the OLIF (oblique lateral interbody fusion) technique for anterior column reconstruction procedures.  

The prestigious award, typically presented during the North American Spine Society (NASS) annual meeting, was presented virtually this year. The annual awards are voted on by a panel of highly accomplished neurosurgeons and orthopedic spine surgeons. The award is graded on originality, clinical relevance, the likelihood of improving patient outcomes, cost-effectiveness, and if the surgeon judging would use the technology.

As a key component of the OLIF technique, Camber’s OLIF Retractor System is designed to enable a highly versatile and safer alternative to a complicated surgical technique. The unique retractor design allows for a safe and customizable retraction of soft tissue and complete visibility of the operative site.

The OLIF technique is a methodology designed by surgeons seeking a less complicated, simpler approach to treating complex spinal pathologies. This procedure takes advantage …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Camber Spine’s OLIF Retractor System Receives ‘2020 Best Spine Technology Award’”

ContextVision Drives Medical Image Enhancement Innovation

contextvision drives medical image enhancement innovation

BEGIN ARTICLE PREVIEW:

Medical Technology Software Company Celebrates Year of Product Expansion and Internal Growth
STOCKHOLM / ACCESSWIRE / December 02, 2020 / ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, announces a progressive year of product innovation and talent acquisition. The company will virtually display its latest advancements in image enhancement as well as introduce new key staff to attendees of RSNA 2020.
Medical ImagingThe release of Rivent, ContextVision’s seventh generation of image enhancement software for 2D ultrasound, was a significant milestone, providing next-level image quality and stronger processing capabilities while retaining a natural look. Addressing the growing need for clearer images and greater value of ultrasound, Rivent provides well defined borders, clear tissue differentiation, and functions for automatic image quality optimization.
Digital PathologyContextVision became a first mover in the rapidly growing digital pathology market with the release of its latest product, INIFY Prostate Screening, a powerful AI-based software that automatically predicts, outlines and quantifies suspicious cancer areas. This investment was a strategic step to capitalizing on the opportunities presented from ongoing efforts toward digitalization.
Talent AcquisitionThe company also prioritized growing its organization, announcing strategic new hires, including:

Ola Lindblad, VP of Medical Imaging – With more than 20 years of experience in the …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “ContextVision Drives Medical Image Enhancement Innovation”